๐Ÿงฌ ๋ฆฌํฌ์ข€ ๊ธฐ์ˆ ์˜ ์„ ๋‘์ฃผ์ž, Liposoma๋ฅผ ์†Œ๊ฐœํ•ฉ๋‹ˆ๋‹ค

๐Ÿงฌ ๋ฆฌํฌ์ข€ ๊ธฐ์ˆ ์˜ ์„ ๋‘์ฃผ์ž, Liposoma๋ฅผ ์†Œ๊ฐœํ•ฉ๋‹ˆ๋‹ค

์„ธ๊ณ„์ ์ธย ๋ฆฌํฌ์ข€ ์ œํ˜•ํ™” ์ „๋ฌธ๊ฐ€ ๊ทธ๋ฃน, Liposoma๋Š” ๋„ค๋œ๋ž€๋“œ ์•”์Šคํ…Œ๋ฅด๋‹ด์— ๋ณธ์‚ฌ๋ฅผ ๋‘” ๋ฐ”์ด์˜คํ…Œํฌ ๊ธฐ์—…์œผ๋กœ,
์˜์•ฝํ’ˆ, ๋ฐฑ์‹ , ์˜์–‘์†Œ ์ „๋‹ฌ ๋ถ„์•ผ์—์„œ ์ตœ์ ํ™”๋œ ๋ฆฌํฌ์ข€ ๊ธฐ์ˆ ์„ ํ†ตํ•ด ๊ณ ๊ฐ ๋งž์ถคํ˜• ์†”๋ฃจ์…˜์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค.

๐ŸŒŸ Why Liposoma?

  • โœ… Cutting-edge Liposome Technology
    ์ •๋ฐ€ํ•˜๊ฒŒ ์ œ์–ด๋œ ํฌ๊ธฐ, ์ „ํ•˜, ์ง€์งˆ ๊ตฌ์„ฑ์˜ ๋ฆฌํฌ์ข€์„ ํ†ตํ•ด ์ƒ์ฒด์ด์šฉ๋ฅ  ํ–ฅ์ƒ ๋ฐ ํ‘œ์  ์ „๋‹ฌ์ด ๊ฐ€๋Šฅํ•ฉ๋‹ˆ๋‹ค.
  • โœ… ๋งž์ถคํ˜• ์„œ๋น„์Šค (Custom Formulation)
    ๋‹จ๋ฐฑ์งˆ, ํ•ต์‚ฐ(mRNA, siRNA), ์†Œ๋ถ„์ž ์•ฝ๋ฌผ๊นŒ์ง€ ๋‹ค์–‘ํ•œ ๋ฌผ์งˆ์— ๋Œ€ํ•œ ๊ณ ๊ฐ ๋งž์ถคํ˜• ๋ฆฌํฌ์ข€ ์„ค๊ณ„๋ฅผ ์ง€์›ํ•ฉ๋‹ˆ๋‹ค.
  • โœ… ํ’ˆ์งˆ๊ณผ ์‹ ๋ขฐ์„ฑ
    GMP ์กฐ๊ฑด์— ๋ถ€ํ•ฉํ•˜๋Š” ์ƒ์‚ฐ๊ณผ ํ’ˆ์งˆ ๊ด€๋ฆฌ ์‹œ์Šคํ…œ์„ ํ†ตํ•ด ์•ˆ์ •์ ์ด๊ณ  ์žฌํ˜„์„ฑ ๋†’์€ ๊ฒฐ๊ณผ๋ฅผ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค.

๐Ÿ’ผ ์ฃผ์š” ์ œํ’ˆ ๋ฐ ์„œ๋น„์Šค

  • Liposomal Drug Formulations (Small molecules, peptides, nucleic acids)
  • Vaccine Adjuvant Systems
  • Liposomal Nutraceuticals
  • Contract Research & Development
  • Stability & Release Profile Studies

๐Ÿ”ฌ ๋Œ€ํ‘œ ์ ์šฉ ๋ถ„์•ผ

  • ํ•ญ์•”์ œ ์ „๋‹ฌ
  • ์œ ์ „์ž ์น˜๋ฃŒ์ œ
  • ๋ฐฑ์‹  ํ”Œ๋žซํผ ๊ฐœ๋ฐœ
  • ๋ฉด์—ญ์กฐ์ ˆ ๋ฌผ์งˆ์˜ ์ „๋‹ฌ
  • ์˜์–‘๋ณด์ถฉ์ œ ๋ฆฌํฌ์ข€ํ™”

๐Ÿ“ฆ Liposoma ์ œํ’ˆ/์„œ๋น„์Šค ๋ฌธ์˜

์•Œ์•ค๋””๋ฉ”์ดํŠธ๋Š” Liposoma์˜ ๊ณต์‹ ํŒŒํŠธ๋„ˆ์‚ฌ๋กœ, ๊ธฐ์ˆ  ์ƒ๋‹ด๋ถ€ํ„ฐ ์ œํ’ˆ ๊ณต๊ธ‰๊นŒ์ง€ ์›์Šคํ†ฑ ์„œ๋น„์Šค๋ฅผ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค.

๐Ÿ‘‰ ๋ฌธ์˜ํ•˜๊ธฐ | ๐Ÿ“ž 070-8028-3500

Liposoma์™€ ํ•จ๊ป˜ ๊ท€์‚ฌ์˜ ๋ฆฌํฌ์ข€ ์ „๋žต์„ ํ•œ ๋‹จ๊ณ„ ๋Œ์–ด์˜ฌ๋ฆฌ์„ธ์š”.
๋ธ”๋กœ๊ทธ๋กœ ๋Œ์•„๊ฐ€๊ธฐ